<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>HIV/AIDS and the Eye</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

  <h1>HIV/AIDS and the Eye</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <p>
                <strong>HIV/AIDS Overview:</strong>
                <ul>
                  <li>HIV/AIDS is a disease of the human immune system</li>
                  <li>Causes gradual decrease in CD4+ T lymphocytes with subsequent opportunistic infections and neoplasia.</li>
                  <li>Ocular involvement in 70-75% of patients</li>
                  <li>HIV-1 & HIV-2</li>
                  <ul>
                    <li>Lentivirus subfamily of retrovirus</li>
                    <li>HIV-1 Most common</li>
                    <li>HIV-2 commoner in West Africa</li>
                  </ul>
                </ul>
              </p>
              
              <p>
                <strong>CD4 Count and Ocular Manifestation:</strong>
                <ul>
                  <li>1000 cells/mm3 - Normal</li>
                  <li>&lt;500 - Kaposi sarcoma, lymphoma, T.B.</li>
                  <li>&lt;250 - Toxoplasma, Pneumocystis carinii</li>
                  <li>&lt;100 - CMV Retinitis, VZ Retinitis, HIV retinopathy, sicca syndrome</li>
                </ul>
              </p>
              
              <p>
                <strong>Ocular Manifestations of HIV/AIDS:</strong>
                <ul>
                  <li><strong>ADNEXAL MANIFESTATIONS</strong></li>
                  <li><strong>ANTERIOR SEGMENT MANIFESTATION</strong></li>
                  <li><strong>POSTERIOR SEGMENT MANIFESTATIONS</strong></li>
                  <li><strong>NEURO-OPHTHALMIC MANIFESTATIONS</strong></li>
                  <li><strong>ORBITAL MANIFESTATIONS</strong></li>
                  <li><strong>DRUG-RELATED OCULAR TOXICITY IN HIV INFECTED PATIENTS</strong></li>
                </ul>
              </p>
              
              <p>
                <strong>Specific Tissue Involvement:</strong>
                <ul>
                  <li><strong>Anterior Segment-</strong> lids, conjunctiva, the lacrimal drainage system, cornea</li>
                  <li><strong>Posterior Segment-</strong> Retina, choroid, and optic nerve</li>
                </ul>
              </p>
              
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Adnexal Manifestations</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Herpes Zoster Ophthalmicus (HZO)</strong></li>
              <li><strong>Kaposi Sarcoma</strong></li>
              <li><strong>Molluscum Contagiosum</strong></li>
              <li><strong>Conjunctival Microvasculopathy (Conjunctival Microvasculopathy)</strong></li>
              <ul>
                <li><strong>70 - 80% of HIV Patients</strong></li>
                <li><strong>Aetiology:</strong></li>
                <ul>
                  <li>- Increased Plasma Viscosity</li>
                  <li>- Immune-Complex Deposition</li>
                  <li>- Direct Infection of the Conjunctival Vascular Endothelium by HIV</li>
                </ul>
                <li>These changes include segmental vascular dilation and narrowing, microaneurysm formation, comma-shaped vascular fragments.</li>
              </ul>
            </ul>
            
                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/" alt="" onclick="openModal(this)">
                            <div class="caption">Conjunctival microvasculopathy‚ÄÉ</div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">Conjunctival microvasculopathy‚ÄÉ</div>
                          </div>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Anterior Segment Manifestation</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Herpes Zoster Ophthalmicus</strong></li>
              <li><strong>Kaposi Sarcoma</strong></li>
              <li><strong>Molluscum Contagiosum</strong></li>
              <li><strong>Keratoconjunctivitis Sicca</strong></li>
              <li><strong>Conjunctival Squamous Cell Carcinoma</strong></li>
              <li><strong>Infectious Keratitis:</strong></li>
              <ul>
                <li><strong>Viral:</strong> Varicella Zoster Virus, HSV I & II</li>
                <li><strong>Fungal:</strong> Fusarium solani, Aspergillus</li>
                <li><strong>Protozoal:</strong> Microsporidia</li>
              </ul>
              <li><strong>Iridocyclitis:</strong> CMV, Varicella Zoster Virus, HSV, or Endogenous autoimmune uveitis like Reiter‚Äôs syndrome</li>
            </ul>
            

            <h4> Molluscum Contagiosum</h4>
            <p>
              <strong>General Information:</strong>
              <ul>
                <li>20% of patients</li>
                <li>Highly contagious dermatitis caused by DNA poxvirus</li>
                <li>May affect mucous membranes as well as skin.</li>
              </ul>
            </p>
            <p>
              <strong>Treatment:</strong> Excision, cryotherapy, topical agents- phenol and trichloroacetic acid.
            </p>
            <p>
              <strong>Manifestations:</strong>
              <ul>
                <li>Adnexal</li>
                <li>Conjunctival</li>
              </ul>
            </p>

            <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption">Molluscum Contagiosum</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Molluscum Contagiosum</div>
              </div>

              <h4>Keratoconjunctivitis Sicca</h4>
              <p>
                <strong>Clinical Features:</strong>
                <ul>
                  <li>Destruction of lacrimal glands</li>
                  <li>Burning uncomfortable red eyes</li>
                </ul>
              </p>
              <p>
                <strong>Treatment:</strong> Artificial tear drops, lubricating ointment
              </p>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption">Keratoconjunctivitis Sicca</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Keratoconjunctivitis Sicca</div>
              </div>
              

              <h4>Herpes Zoster Ophthalmicus</h4>
              <p>
                <strong>Clinical Features:</strong>
                <ul>
                  <li>Herpes Zoster virus</li>
                  <li>Reactivation</li>
                  <li>Dermatomal pain, Rash</li>
                </ul>
              </p>
              <p>
                <strong>Ocular Manifestations:</strong>
                <ul>
                  <li>Keratitis</li>
                  <li>Conjunctivitis, episcleritis, scleritis, uveitis, glaucoma, pthisis bulbi</li>
                </ul>
              </p>
              <p>
                <strong>Treatment:</strong> Acyclovir 3% eye ointment 5 times/day, Tab Acyclovir 800mg 5 times/day
              </p>
              

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption">Herpes Zoster Ophthalmicus</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Herpes Zoster Ophthalmicus</div>
              </div>

              <h4>Anterior Uveitis</h4>
              <ul>
                <li>Herpes simplex</li>
                <li>Herpes Zoster</li>
                <li>CMV</li>
                <li>Toxoplasmosis</li>
                <li>Syphilis</li>
                <li>Drug induced - Rifabutin</li>
              </ul>
              
              <h4>Kaposi Sarcoma</h4>
              <p>
                <strong>Clinical Features:</strong>
                <ul>
                  <li>Vascular neoplasm</li>
                  <li>Commonest anterior segment lesion</li>
                  <li>Affects the eyelids (purple nodules), or conjunctiva ‚Äì red mass</li>
                </ul>
              </p>
              <p>
                <strong>Treatment:</strong>
                <ul>
                  <li>Radiation therapy</li>
                  <li>Intralesional chemotherapy</li>
                  <li>Surgical excision</li>
                </ul>
              </p>
              
                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>


              <h4>Conjunctival Squamous Cell Carcinoma</h4>
              <p>
                <strong>Clinical Features:</strong>
                <ul>
                  <li>Pink gelatinous growth on the bulbar conjunctiva</li>
                  <li>Interaction between HIV, sunlight, HPV</li>
                  <li>Feeding blood vessel</li>
                </ul>
              </p>
              <p>
                <strong>Treatment:</strong>
                <ul>
                  <li>Excision & cryotherapy</li>
                  <li>Exenteration ‚Äì if orbit involved</li>
                </ul>
              </p>
              
                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Posterior Segment Manifestation</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>HIV Retinopathy</strong></li>
              <li><strong>HIV-Linked Retinochoroiditis</strong></li>
              <li><strong>Cytomegalovirus Retinitis</strong></li>
            </ul>
            

<h4>HIV Retinopathy</h4>
<p>
  <strong>Common Features:</strong>
  <ul>
    <li>Commonest retinal pathology in HIV</li>
    <li>Characteristic cotton wool spots</li>
  </ul>
</p>
<p>
  <strong>Cause:</strong>
  <ul>
    <li>Due to microangiopathy induced by plasma hyperviscosity, immune complex deposition, or direct viral endothelial attachment</li>
  </ul>
</p>

<h4>HIV-Linked Retinochoroiditis</h4>
<p>
  <strong>Viral:</strong>
  <ul>
    <li>Varicella Zoster - Progressive Outer Retinal Necrosis (PORN)</li>
    <li>Herpes Simplex - Anterior Retinal Necrosis (ARN)</li>
  </ul>
</p>
<p>
  <strong>Bacterial:</strong>
  <ul>
    <li>Treponema Pallidum (Syphilis)</li>
    <li>Mycobacterium Tuberculosis</li>
  </ul>
</p>
<p>
  <strong>Fungal:</strong>
  <ul>
    <li>Cryptococcus Neoformans</li>
    <li>Histoplasma Capsulatum</li>
    <li>Candida</li>
    <li>Aspergillus</li>
  </ul>
</p>
<p>
  <strong>Parasitic:</strong>
  <ul>
    <li>Toxoplasma Gondii</li>
    <li>Pneumocystis</li>
  </ul>
</p>

<h4>Cytomegalovirus Retinitis</h4>
<p>
  <strong>Overview:</strong>
  <ul>
    <li>Most common intraocular infection in HIV</li>
    <li>Transmitted by close contact in children, by sexual contact, and blood transfusion in adolescence and adults</li>
    <li>Primary infection is asymptomatic</li>
    <li>Secondary reactivated infection is life and vision-threatening</li>
  </ul>
</p>

<p>
  <strong>Symptoms:</strong>
  <ul>
    <li>Floaters</li>
    <li>Decreased vision</li>
    <li>Flashes or asymptomatic</li>
  </ul>
</p>

<p>
  <strong>Clinical Signs:</strong>
  <ul>
    <li>Tomato ketchup appearance</li>
    <li>Progress in brushfield pattern</li>
    <li>Retinal detachment may occur</li>
  </ul>
</p>


<h4>CMV Retinitis</h4>

<p>
  <strong>Treatment:</strong>
  <ul>
    <li>IV Gancyclovir initially, then oral</li>
    <li>Intravitreal injections ‚Äì 200 - 2000ug/0.1 ml</li>
    <li>Bone marrow suppression may occur</li>
  </ul>
</p>

<p>
  <strong>Alternative Treatments:</strong>
  <ul>
    <li>IV Foscarnet ‚Äì for gancyclovir-resistant cases, also administered intravitreally</li>
    <li>Valgancyclovir:
      <ul>
        <li>Induction ‚Äì 900mg BD</li>
        <li>Maintenance ‚Äì 900mg OD</li>
      </ul>
    </li>
    <li>Cidofovir ‚Äì 5mg/kg IV once weekly for 2 weeks + probenecid</li>
  </ul>
</p>

<h4>ACUTE RETINAL NECROSIS</h4>

<p>
  <strong>Causative Agent:</strong> Herpes Zoster infection
</p>

<p>
  <strong>Clinical Features:</strong>
  <ul>
    <li>Vitritis</li>
    <li>Macular edema</li>
    <li>Peripheral whitening retinal lesions</li>
  </ul>
</p>

<p>
  <strong>Treatment:</strong>
  <ul>
    <li>Acyclovir IV for 14 days</li>
    <li>Followed by oral acyclovir 5 times daily for 6-12 weeks</li>
  </ul>
</p>


            <!-- image here -->
            <div class="image-container">
              <img src="../figures/" alt="" onclick="openModal(this)">
              <div class="caption"></div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption"></div>
            </div>

            <h4>PROGRESSIVE OUTER RETINAL NECROSIS (PORN)</h4>

            <p>
              <strong>Causative Agent:</strong> Varicella Zoster virus
            </p>
            
            <p>
              <strong>Clinical Features:</strong>
              <ul>
                <li>White lesions in mid & peripheral retina</li>
                <li>Rapid loss of vision</li>
              </ul>
            </p>
            
            <p>
              <strong>Treatment:</strong>
              <ul>
                <li>IV gancyclovir or Foscarnet</li>
                <li>Intravitreal foscarnet</li>
              </ul>
            </p>
            
            <p>
              <strong>Prognosis:</strong> Poor
            </p>

            

            <h4>TOXOPLASMA CHORIORETINITIS</h4>

<p>
  <strong>Causative Agent:</strong> Protozoan disease - Toxoplasma gondii
</p>

<p>
  <strong>Associated Conditions:</strong> Also causes encephalitis
</p>

<p>
  <strong>Clinical Features:</strong>
  <ul>
    <li>Floaters, flashes, reduced vision</li>
    <li>Headlight in the fog appearance</li>
  </ul>
</p>

<p>
  <strong>Treatment:</strong> Steroids, clindamycin, sulphadiazine
</p>


<h4>SYPHILIS</h4>

<p>
  <strong>Clinical Manifestations:</strong>
  <ul>
    <li>Uveitis</li>
    <li>Retinitis</li>
    <li>Optic neuritis</li>
    <li>Papillodema</li>
  </ul>
</p>

<p>
  <strong>Treatment:</strong> High dose iv penicillin
</p>



<h4>FUNGAL INFECTION</h4>

<p>
  <strong>Candida & Cryptococcus:</strong>
  <ul>
    <li>Snowball-like lesions</li>
    <li>Neuropathy</li>
  </ul>
</p>

<p>
  <strong>Treatment:</strong> Amphotericin B + Fluconazole
</p>


<h4>TUBERCULOSIS</h4>

<p>
  <strong>Ocular Manifestations:</strong>
  <ul>
    <li>The most common ocular manifestation is anterior uveitis and choroiditis.</li>
    <li>Manifests as areas of necrosis surrounded by mononuclear and giant cells.</li>
    <li>Unifocal/multifocal yellowish or whitish choroiditis.</li>
  </ul>
</p>



        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Neuro-ophthalmic Manifestations</a>
          </h2>
        </header>
        <div class='body'>
          <p>
            <strong>Prevalence:</strong> 10-15% of patients
          </p>
          
          <p>
            <strong>Common Causes:</strong> Meningitis, Meningeal Lymphoma, Neurosyphilis, Toxoplasmosis.
          </p>
          
          <p>
            <strong>Neuro-ophthalmic Manifestations:</strong>
            <ul>
              <li>Papilledema due to increased intracranial pressure</li>
              <li>Optic neuritis</li>
              <li>Cranial nerve palsies</li>
              <li>Ocular motility disorders</li>
              <li>Visual field defects</li>
            </ul>
          </p>
          
          <p>
            <strong>Treatment:</strong>
            <ul>
              <li>Antibiotic Rx for infectious causes</li>
              <li>Systemic steroids in severe cases of optic neuritis</li>
              <li>Radiation and chemotherapy for lymphoma</li>
            </ul>
          </p>
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Orbital Manifestations</a>
          </h2>
        </header>
        <div class='body'>
          <p>
            <strong>Common Complications:</strong>
            <ul>
              <li>Orbital lymphoma</li>
              <li>Orbital cellulitis (Aspergillus infection)</li>
              <li>Orbital Kaposi sarcoma</li>
            </ul>
          </p>
          
          <p>
            <strong>Treatment:</strong>
            <ul>
              <li>Lymphomas - treated with radiation and chemotherapy</li>
              <li>Orbital cellulitis - systemic antibiotics</li>
            </ul>
          </p>
          
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> </a>
          </h2>
        </header>
        <div class='body'>
          <h4>Antiretroviral Drug-Related Toxicity</h4>

          <p>
            <strong>Rifabutin:</strong> Intraocular inflammation (uveitis) - 33%
          </p>
          
          <p>
            <strong>Cidofovir:</strong> Uveitis and intraocular hypotony - 25-30%
          </p>
          
          <p>
            <strong>Didanosine:</strong> Retinal pigment epithelial abnormalities
          </p>
          
          <p>
            <strong>Long-term Atovaquone:</strong> Corneal subepithelial deposits
          </p>
          
          <p>
            The drug toxicities are dose-related and resolve with discontinuation of the drug.
          </p>
          
        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this ‚ÄòWebsite‚Äô, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
